We would like to invite you to participate in the 10th Inhibitors of Protein Kinases Conference joined with the 2nd Challenges in Molecular Biology, Biophysics and Biomedicine Meeting, which will be held 14th -18th of September 2019, Warsaw, Poland. The preliminary list of invited speakers is attached at the end of the letter.
Protein and lipid kinases stand in the spotlight of academic and industrial research. The launched drugs Gefitinib, Erlotinib, and Gleevec have already helped to save thousands of lives by inhibition of specific kinases leading to the reduction of cancer growth.
Protein phosphorylation is the most important pathway for regulation of protein function in the living cells. It is involved in the switching of cellular activities from one state to another and, in this way, regulates gene expression, cellular proliferation, and differentiation. It is the major mechanism by which cells respond to extracellular signals, such as hormones and growth factors, and control all events at the various stages of the cell cycle. Moreover, protein phosphorylation enables cell’s response to environmental and nutritional stress factors. Besides cancer, the inhibition of kinases may be the key to the treatment of other diseases, including neurological and autoimmune diseases.
Over the last 18 years biannual IPK Conference, organized and mentored by Prof. David Shugar, brought together the top international kinase researchers from academia and industry. We plan to build on the success of the previous meetings and broaden the topics to include current trends in kinase inhibition. As we have done in the past, we assembled world leading researchers to serve as a magnet for even more successful meeting in 2019.